Evolent Health (EVH) Short-term Investments (2015 - 2026)

Evolent Health's Short-term Investments history runs 12 years deep, the most recent figure standing at $24.0 million for Q1 2026.

• In Q1 2026, Short-term Investments rose 47.65% year-over-year to $24.0 million; the TTM figure through Mar 2026 stood at $24.0 million (up 47.65% YoY), while the FY2025 annual figure was $26.1 million, down 55.93% from the prior year.
• Short-term Investments was $24.0 million for Q1 2026 at Evolent Health, down from $26.1 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $74.4 million in Q2 2022 to a low of $13.8 million in Q4 2023.
• Historically, Short-term Investments has averaged $30.7 million across 5 years, with a median of $24.0 million in 2026.
• The sharpest annual moves came in 2022 and 2024: Short-term Investments plunged 80.85% in 2022, then jumped 330.67% in 2024.
• A 5-year view of Short-term Investments shows it stood at $14.5 million in 2022, then fell by 5.0% to $13.8 million in 2023, then jumped by 330.67% to $59.3 million in 2024, then plunged by 55.93% to $26.1 million in 2025, then dropped by 8.25% to $24.0 million in 2026.
• The last three Short-term Investments figures came in at $24.0 million (Q1 2026), $26.1 million (Q4 2025), and $23.7 million (Q3 2025), per Business Quant data.